MUC1 and pulmonary fibrosis: Increased KL-6 concentrations have been previously reported in different pulmonary diseases, including hypersensitivity pneumonitis [34], idiopathic pulmonary fibrosis [13,14], acute respiratory distress syndrome [15], lung cancer [35], and pulmonary sarcoidosis [8].